These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11008719)

  • 1. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission.
    Van Kemseke C; Belaiche J; Louis E
    Int J Colorectal Dis; 2000 Aug; 15(4):206-10. PubMed ID: 11008719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.
    Louis E; Belaiche J; van Kemseke C; Franchimont D; de Groote D; Gueenen V; Mary JY
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):939-44. PubMed ID: 9391781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.
    Mavropoulou E; Mechie NC; Knoop R; Petzold G; Ellenrieder V; Kunsch S; Pilavakis Y; Amanzada A
    PLoS One; 2020; 15(5):e0233811. PubMed ID: 32470973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
    Crabtree JE; Juby LD; Heatley RV; Lobo AJ; Bullimore DW; Axon AT
    Gut; 1990 Sep; 31(9):1033-6. PubMed ID: 2210449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
    Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
    Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease.
    Proujansky R; Carpenter AB
    J Pediatr Gastroenterol Nutr; 1991 Oct; 13(3):277-84. PubMed ID: 1791504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
    Brynskov J; Tvede N
    Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
    Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
    J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis Markers Soluble IL-2 Receptor and Soluble CD14 Subtype as Potential Biomarkers for Complete Mucosal Healing in Patients With Inflammatory Bowel Disease.
    Hosomi S; Yamagami H; Itani S; Yukawa T; Otani K; Nagami Y; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
    J Crohns Colitis; 2018 Jan; 12(1):87-95. PubMed ID: 28961693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse.
    Louis E; Belaiche J; Van Kemseke C; Schaaf N; Mahieu P; Mary JY
    Dig Dis Sci; 1995 Aug; 40(8):1750-6. PubMed ID: 7648975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor and disease activity in Crohn's disease.
    Williams AJ; Symons JA; Watchet K; Duff GW
    J Autoimmun; 1992 Apr; 5(2):251-9. PubMed ID: 1627235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.
    Mitsuyama K; Toyonaga A; Sasaki E; Ishida O; Ikeda H; Tsuruta O; Harada K; Tateishi H; Nishiyama T; Tanikawa K
    Gut; 1995 Jan; 36(1):45-9. PubMed ID: 7890234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
    Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
    Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
    Wu LJ; Chen KY; Chi KH; Chen SY; Liang MJ; Shiau CY; Wang LW; Liu YM; Chow KC; Yen SH
    Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.